imphatec
Medical Technologies & Devices
- Website
- https://imphatec.com
- Membership category
- Emerging Y1
Oak Cottage, Langley Bridge, Liss, GU33 7JR, United Kingdom
imphatec at a glance
imphatec is developing the first customisable-dose subcutaneous implant platform for the treatment of chronic and long-term conditions.
About imphatec
imphatec Ltd. is a British synthetic biology pharmaceutical company developing the first customisable-dose subcutaneous implant platform for the treatment of chronic and long-term conditions. imphatec’s implants remove the need for manual compliance with daily medication, by releasing medication into the patient over the long term, with the dose released from the implants customisable to the individual patient. The company was co-founded by Mr James P. Catt (CEO) and Dr Hassan O. J. Morad (CSO).
